January 2, 2008
Echo Begins Glucose Trial
By Matthew L. Brown
Franklin-based medical products maker Echo Therapeutics Inc. , formerly Sontra Medical Corp., said it had started the second clinical trial of a wireless, needle-free, continuous blood glucose monitoring system.
The study is being conducted at Tufts New England Medical Center, and Echo expects to announce results of the trial in the first quarter of the year.
The system, which is called Symphony CTGM, is designed to provide glucose monitoring for diabetes patients as well as help hospitals better monitor and control glucose levels in other patients.
Bayer holds certain licensing rights to the Symphony CTGM system.
The study is being conducted at Tufts New England Medical Center, and Echo expects to announce results of the trial in the first quarter of the year.
The system, which is called Symphony CTGM, is designed to provide glucose monitoring for diabetes patients as well as help hospitals better monitor and control glucose levels in other patients.
Bayer holds certain licensing rights to the Symphony CTGM system.
WBJ Web Partners
Most Recent
Most Recent
0 Comments